You are required to be logged in to access the full website
User Name: Password:
Click here if you have forgotten your username or password
  • Home
  • Latest News
  • Search
  • About M2 Pharma
  • Subscribe
Business & Finance
Generics
Therapy Areas
Policy & Regulation
Research & Development
People
Policy & Regulation
Calidi Biotherapeutics Names Heehyoung Lee to Board of Directors
Login
Username:

Password:


Related Headlines

GE HealthCare and Mayo Clinic launch prostate cancer theranostics research study

Helix partners with AstraZeneca to support genomic research for drug discovery and development

Insilico initiates Rentosertib Phase III clinical trial for idiopathic pulmonary fibrosis

Invictus Pharmacy and Mullan Pharmaceutical partner to expand patient access to Ganirelix Acetate Injection

Wiley announces launch of Advanced Immunology open access journal

Ascletis submits two IND applications to US FDA for obesity treatments

AbbVie's TEPKINLY (epcoritamab) combination approved in Europe to treat relapsed or refractory follicular lymphoma

Aurinia initiates PRESERVE Phase 4 study of LUPKYNIS combination therapy in lupus nephritis

Anixa Biosciences advances ovarian cancer CAR-T trial to highest dose level

Taiwan biomedical startups hold over 100 business meetings at BIO 2026

Brii Bio reports Phase 2 end-of-treatment data in chronic hepatitis B

Nona Biosciences names new chief operating officer

SK bioscience to lead Gates Foundation-funded ROTOR project

Data from Partner Therapeutics' eNRGy trial of zenocutuzumab published in Journal of Clinical Oncology

Arcturus Therapeutics and Thermo Fisher enter strategic collaboration on ARCT-032 development

Home | Business & Finance | Generics | Therapy Areas | Policy & Regulation | Research & Development | People | Search | About M2 Pharma | Subscribe
Copyright © 2026